BCYC — Bicycle Therapeutics Share News
0.000.00%
Last trade - 00:00- $267.37m
- -$241.92m
- $72.59m
Brief: Bicycle Therapeutics's Cash Position Of $339.2 Mln, To Provide Financial Runway
Bicycle Therapeutics PLC reports results for the quarter ended in December - Earnings Summary
Bicycle Therapeutics PLC expected to post a loss of $1.06 a share - Earnings Preview
Bicycle Therapeutics PLC expected to post a loss of $1.06 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Packaged food makers, energy firms, Thomson Reuters
U.S. STOCKS ON THE MOVE-Ford Motor, Cleveland-Cliffs, Exelon Corp
Bicycle Therapeutics rises as cancer drug study shows positive response
Bicycle Therapeutics rises on 'fast track' tag for cancer therapy
Brief: Bicycle Therapeutics Announces FDA Fast Track Designation For Bt8009
Bicycle Therapeutics PLC reports results for the quarter ended in September - Earnings Summary
Brief: Bicycle Therapeutics Reports Third Quarter 2022 Financial Results
Bicycle Therapeutics PLC expected to post a loss of 89 cents a share - Earnings Preview
Brief: Bicycle Therapeutics Announces Publication Of Article Highlighting Preclinical Data From BT8009 Program
Brief: Bicycle Therapeutics Announces Bt5528 Phase I Dose Escalation Results In Patients With Advanced Solid Tumors
U.S. STOCKS ON THE MOVE-Pfizer, Nvidia, Boeing, SAIC, BioAffinity, Polestar
U.S. STOCKS ON THE MOVE-Kroger, J.Jill, Twin Disc, Abbvie
U.S. STOCKS ON THE MOVE-Arcturus, Five Below, Mullen
U.S. STOCKS ON THE MOVE-Nvidia, Nutanix, Comera, chip stocks
Cowen starts Bicycle Therapeutics with 'outperform' rating